3D-PharmXchange3D-PharmXchange is a Dutch consultancy firm specialized on early pharmaceuticals development: transitioning molecules (small molecules, peptides, biologics, ADCs, vaccines, ATMPs) from late-stage discovery into development, early CMC, pre-clinical (ADME/Tox, animal studies), clinical (phase 1-3), regulatory (FDA, EMA), and project management in a wide range of indications including oncology, CNS, cardiovascular, respiratory, infectious diseases and women's health. We are also involved in a number of COVID-19 projects for inhalation and injectable drugs.
